Japanese pharmaceutical companies have an eye on the OTC market in Korea
Japanese pharmaceutical companies have an eye on the OTC market in Korea.
Kowa Korea plans to focus on OTC sales. On June 2, Kowa Korea officially launched Cabagin Kowa S tablet in Korea market which contains cabbage origin ingredient MMS, and challenges in earnest.
Takeda Korea which succeeded...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
